Research graph

References

References from Abstract No: 595 INDIVIDUALIZED TREATMENT EFFECTS OF FINERENONE VERSUS SPIRONOLACTONE IN STAGES 2-4 CARDIOVASCULAR-KIDNEY-METABOLIC SYNDROME. Local targets link to admitted publications; unresolved targets remain external evidence.

No reference evidence is available for this admitted work.